Despite their toxicological effects, cytochalasins have been explored for potential therapeutic applications. Their ability to disrupt actin dynamics can be harnessed to inhibit the proliferation of cancer cells, and they have been studied as potential anticancer agents. However, their use in medicine is limited due to the challenge of selectively targeting cancer cells without affecting normal cells.
